UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4552-4564

2022

Link zum Volltext

Verfügbarkeit prüfen

Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects

PloS one, 2014-11, Vol.9 (11), p.e111838-e111838

2014

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia

ChemMedChem, 2018-05, Vol.13 (10), p.988-1003

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers

Clinical pharmacology in drug development, 2019-05, Vol.8 (4), p.467-479

2019

Link zum Volltext

Verfügbarkeit prüfen

Application of accelerated solvent extraction followed by gas chromatography, high-performance liquid chromatography and gas chromatography–mass spectrometry for the determination of polycyclic aromatic hydrocarbons, chlorinated pesticides and polychlorinated dibenzo- p-dioxins and dibenzofurans in solid wastes

Journal of Chromatography A, 1997-07, Vol.774 (1), p.203-211

1997

Link zum Volltext

Verfügbarkeit prüfen

Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy

Radiology, 2024-01, Vol.310 (1), p.e231984

2024

Link zum Volltext

Verfügbarkeit prüfen

Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models

International journal of cancer, 2019-09, Vol.145 (5), p.1346-1357

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Safety, and Tolerability of the α 2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects

Clinical pharmacology in drug development, 2022-03, Vol.11 (3), p.296-308

2022

Link zum Volltext

Verfügbarkeit prüfen

Mass spectrometric characterization of the hypoxia‐inducible factor (HIF) stabilizer drug candidate BAY 85‐3934 (molidustat) and its glucuronidated metabolite BAY‐348, and their implementation into routine doping controls

Drug testing and analysis, 2017-01, Vol.9 (1), p.61-67

2017

Link zum Volltext

Verfügbarkeit prüfen

Front Cover: Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia (ChemMedChem 10/2018)

ChemMedChem, 2018-05, Vol.13 (10), p.981-981

2018

Link zum Volltext

Verfügbarkeit prüfen

Determination of nifurtimox in dog plasma by stable-isotope dilution LC-MS/MS

Bioanalysis, 2015-11, Vol.7 (21), p.2777-2787

2015

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular effects of the soluble guanylyl cyclase activator BAY 58–2667 in anesthetized dogs

BMC pharmacology, 2007-07, Vol.7 (S1), p.P28-P28, Article P28

2007

Link zum Volltext

Verfügbarkeit prüfen

Penetration of moxifloxacin into rat mandibular bone and soft tissue

Acta odontologica Scandinavica, 2009, Vol.67 (3), p.182-186

2009

Link zum Volltext

Verfügbarkeit prüfen

Chlorobenzenes and hexachlorocyclohexanes (HCHs) in the atmosphere of Bitterfeld and Leipzig (Germany)

Chemosphere (Oxford), 2000-09, Vol.41 (6), p.849-855

2000

Link zum Volltext

Verfügbarkeit prüfen

Identification and Quantification of Thiaarenes in the Flue Gas of Lignite-Fired Domestic Heating

Journal of high resolution chromatography, 2000-08, Vol.23 (7-8), p.457-473

2000

Link zum Volltext

Verfügbarkeit prüfen

Incidence of metachronous peritoneal metastases for intrahepatic cholangiocarcinoma after curative resection: A single center cohort analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16199-e16199

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence of synchronous and metachronous peritoneal metastases for gallblader cancer: A single-center cohort analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16191-e16191

2023

Link zum Volltext

Verfügbarkeit prüfen

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment

Palliative care and social practice, 2024-01, Vol.18, p.26323524241260424

2024

Link zum Volltext

Verfügbarkeit prüfen

Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4033-4033

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics

Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects

Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia

Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers

Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy

Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models

Pharmacokinetics, Safety, and Tolerability of the α 2C -Adrenoreceptor Antagonist BAY 1193397 in Healthy Male Subjects

Mass spectrometric characterization of the hypoxia‐inducible factor (HIF) stabilizer drug candidate BAY 85‐3934 (molidustat) and its glucuronidated metabolite BAY‐348, and their implementation into routine doping controls

Front Cover: Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia (ChemMedChem 10/2018)

Determination of nifurtimox in dog plasma by stable-isotope dilution LC-MS/MS

Cardiovascular effects of the soluble guanylyl cyclase activator BAY 58–2667 in anesthetized dogs

Penetration of moxifloxacin into rat mandibular bone and soft tissue

Chlorobenzenes and hexachlorocyclohexanes (HCHs) in the atmosphere of Bitterfeld and Leipzig (Germany)

Identification and Quantification of Thiaarenes in the Flue Gas of Lignite-Fired Domestic Heating

Incidence of metachronous peritoneal metastases for intrahepatic cholangiocarcinoma after curative resection: A single center cohort analysis

Incidence of synchronous and metachronous peritoneal metastases for gallblader cancer: A single-center cohort analysis

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment

Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie)

Aktive Filter

Suchergebnisse filtern